Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Fielding

Showing results (681-690 of 713) with videos related to

Pageof 72
Sort By:
Aging Clinical and Experimental Research|July 27, 2024
An executive summary on the Global conceptual definition of SarcopeniaBen Kirk, Peggy M Cawthon, Hidenori Arai, et al.
Calcified Tissue International|May 18, 2019
Is There Enough Evidence for Osteosarcopenic Obesity as a Distinct Entity? A Critical Literature ReviewJürgen M Bauer, Alfonso J Cruz-Jentoft, Roger A Fielding, et al.
Ageing Research Reviews|May 28, 2018
Evidence-based nutritional and pharmacological interventions targeting chronic low-grade inflammation in middle-age and older adults: A systematic review and meta-analysisC Custodero, R T Mankowski, S A Lee, et al.
Aging Clinical and Experimental Research|January 1, 2016
Recommendations for the conduct of clinical trials for drugs to treat or prevent sarcopeniaJean-Yves Reginster, Cyrus Cooper, René Rizzoli, et al.
Journal of the American Medical Directors Association|April 30, 2011
Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence, etiology, and consequences. International working group on sarcopeniaRoger A Fielding, Bruno Vellas, William J Evans, et al.
Calcified Tissue International|July 25, 2019
Correction to: Is There Enough Evidence for Osteosarcopenic Obesity as a Distinct Entity? A Critical Literature ReviewJürgen M Bauer, Alfonso J Cruz-Jentoft, Roger A Fielding, et al.
Journal of the American Geriatrics Society|July 8, 2020
Putative Cut-Points in Sarcopenia Components and Incident Adverse Health Outcomes: An SDOC AnalysisPeggy M Cawthon, Todd Manini, Sheena M Patel, et al.
Age and Ageing|March 23, 2024
The Conceptual Definition of Sarcopenia: Delphi Consensus from the Global Leadership Initiative in Sarcopenia (GLIS)Ben Kirk, Peggy M Cawthon, Hidenori Arai, et al.
Journal of the American Geriatrics Society|July 23, 2017
ENabling Reduction of Low-grade Inflammation in SEniors Pilot Study: Concept, Rationale, and DesignTodd M Manini, Stephen D Anton, Daniel P Beavers, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|December 13, 2018
Effect of Losartan and Fish Oil on Plasma IL-6 and Mobility in Older Persons. The ENRGISE Pilot Randomized Clinical TrialMarco Pahor, Stephen D Anton, Daniel P Beavers, et al.
Pageof 72

Showing results (681-690 of 713) with videos related to

Sort By:
Pageof 72
Aging Clinical and Experimental Research|July 27, 2024
An executive summary on the Global conceptual definition of SarcopeniaBen Kirk, Peggy M Cawthon, Hidenori Arai, et al.
Calcified Tissue International|May 18, 2019
Is There Enough Evidence for Osteosarcopenic Obesity as a Distinct Entity? A Critical Literature ReviewJürgen M Bauer, Alfonso J Cruz-Jentoft, Roger A Fielding, et al.
Ageing Research Reviews|May 28, 2018
Evidence-based nutritional and pharmacological interventions targeting chronic low-grade inflammation in middle-age and older adults: A systematic review and meta-analysisC Custodero, R T Mankowski, S A Lee, et al.
Aging Clinical and Experimental Research|January 1, 2016
Recommendations for the conduct of clinical trials for drugs to treat or prevent sarcopeniaJean-Yves Reginster, Cyrus Cooper, René Rizzoli, et al.
Journal of the American Medical Directors Association|April 30, 2011
Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence, etiology, and consequences. International working group on sarcopeniaRoger A Fielding, Bruno Vellas, William J Evans, et al.
Calcified Tissue International|July 25, 2019
Correction to: Is There Enough Evidence for Osteosarcopenic Obesity as a Distinct Entity? A Critical Literature ReviewJürgen M Bauer, Alfonso J Cruz-Jentoft, Roger A Fielding, et al.
Journal of the American Geriatrics Society|July 8, 2020
Putative Cut-Points in Sarcopenia Components and Incident Adverse Health Outcomes: An SDOC AnalysisPeggy M Cawthon, Todd Manini, Sheena M Patel, et al.
Age and Ageing|March 23, 2024
The Conceptual Definition of Sarcopenia: Delphi Consensus from the Global Leadership Initiative in Sarcopenia (GLIS)Ben Kirk, Peggy M Cawthon, Hidenori Arai, et al.
Journal of the American Geriatrics Society|July 23, 2017
ENabling Reduction of Low-grade Inflammation in SEniors Pilot Study: Concept, Rationale, and DesignTodd M Manini, Stephen D Anton, Daniel P Beavers, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|December 13, 2018
Effect of Losartan and Fish Oil on Plasma IL-6 and Mobility in Older Persons. The ENRGISE Pilot Randomized Clinical TrialMarco Pahor, Stephen D Anton, Daniel P Beavers, et al.
Pageof 72